These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 12784269

  • 1. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease.
    Paus S, Brecht HM, Köster J, Seeger G, Klockgether T, Wüllner U.
    Mov Disord; 2003 Jun; 18(6):659-67. PubMed ID: 12784269
    [Abstract] [Full Text] [Related]

  • 2. Predictors of impaired daytime sleep and wakefulness in patients with Parkinson disease treated with older (ergot) vs newer (nonergot) dopamine agonists.
    Razmy A, Lang AE, Shapiro CM.
    Arch Neurol; 2004 Jan; 61(1):97-102. PubMed ID: 14732626
    [Abstract] [Full Text] [Related]

  • 3. Sleepiness in Parkinson's disease: a controlled study.
    Brodsky MA, Godbold J, Roth T, Olanow CW.
    Mov Disord; 2003 Jun; 18(6):668-72. PubMed ID: 12784270
    [Abstract] [Full Text] [Related]

  • 4. Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study.
    Romigi A, Brusa L, Marciani MG, Pierantozzi M, Placidi F, Izzi F, Sperli F, Testa F, Stanzione P.
    J Neurol Sci; 2005 Jan 15; 228(1):7-10. PubMed ID: 15607203
    [Abstract] [Full Text] [Related]

  • 5. Excessive daytime sleepiness in parkinsonism.
    Arnulf I.
    Sleep Med Rev; 2005 Jun 15; 9(3):185-200. PubMed ID: 15893249
    [Abstract] [Full Text] [Related]

  • 6. Excessive daytime sleepiness and sleep episodes in Japanese patients with Parkinson's disease.
    Suzuki K, Miyamoto T, Miyamoto M, Okuma Y, Hattori N, Kamei S, Yoshii F, Utsumi H, Iwasaki Y, Iijima M, Hirata K.
    J Neurol Sci; 2008 Aug 15; 271(1-2):47-52. PubMed ID: 18436241
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Sudden uncontrollable somnolence and medication use in Parkinson disease.
    Avorn J, Schneeweiss S, Sudarsky LR, Benner J, Kiyota Y, Levin R, Glynn RJ.
    Arch Neurol; 2005 Aug 15; 62(8):1242-8. PubMed ID: 16087765
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of sleep and driving performance in six patients with Parkinson's disease reporting sudden onset of sleep under dopaminergic medication: a pilot study.
    Möller JC, Stiasny K, Hargutt V, Cassel W, Tietze H, Peter JH, Krüger HP, Oertel WH.
    Mov Disord; 2002 May 15; 17(3):474-81. PubMed ID: 12112193
    [Abstract] [Full Text] [Related]

  • 10. 'Sleep attacks' or 'unintended sleep episodes' occur with dopamine agonists: is this a class effect?
    Chaudhuri KR, Pal S, Brefel-Courbon C.
    Drug Saf; 2002 May 15; 25(7):473-83. PubMed ID: 12093305
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Bedtime cabergoline in Parkinson's disease patients with excessive daytime sleepiness induced by dopamine agonists.
    Del Dotto P, Gambaccini G, Caneparo D, Berti C, Bernardini S, Bonuccelli U.
    Neurol Sci; 2003 Oct 15; 24(3):170-1. PubMed ID: 14598071
    [Abstract] [Full Text] [Related]

  • 13. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group.
    Hobson DE, Lang AE, Martin WR, Razmy A, Rivest J, Fleming J.
    JAMA; 2003 Oct 15; 287(4):455-63. PubMed ID: 11798367
    [Abstract] [Full Text] [Related]

  • 14. Dopamine receptor gene polymorphisms in Parkinson's disease patients reporting "sleep attacks".
    Rissling I, Geller F, Bandmann O, Stiasny-Kolster K, Körner Y, Meindorfner C, Krüger HP, Oertel WH, Möller JC.
    Mov Disord; 2004 Nov 15; 19(11):1279-84. PubMed ID: 15390060
    [Abstract] [Full Text] [Related]

  • 15. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
    Pal S, Bhattacharya KF, Agapito C, Chaudhuri KR.
    J Neural Transm (Vienna); 2001 Nov 15; 108(1):71-7. PubMed ID: 11261748
    [Abstract] [Full Text] [Related]

  • 16. Effects of ropinirole prolonged-release on sleep disturbances and daytime sleepiness in Parkinson disease.
    Dusek P, Busková J, Růzicka E, Majerová V, Srp A, Jech R, Roth J, Sonka K.
    Clin Neuropharmacol; 2010 Jul 15; 33(4):186-90. PubMed ID: 20661025
    [Abstract] [Full Text] [Related]

  • 17. Predictors of sudden onset of sleep in Parkinson's disease.
    Körner Y, Meindorfner C, Möller JC, Stiasny-Kolster K, Haja D, Cassel W, Oertel WH, Krüger HP.
    Mov Disord; 2004 Nov 15; 19(11):1298-305. PubMed ID: 15389999
    [Abstract] [Full Text] [Related]

  • 18. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease?
    Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP.
    Neurology; 2006 Sep 12; 67(5):853-8. PubMed ID: 16966550
    [Abstract] [Full Text] [Related]

  • 19. Dopamine agonists induce episodes of irresistible daytime sleepiness.
    Schlesinger I, Ravin PD.
    Eur Neurol; 2003 Sep 12; 49(1):30-3. PubMed ID: 12464715
    [Abstract] [Full Text] [Related]

  • 20. Excessive daytime sleepiness in de novo and treated Parkinson's disease.
    Fabbrini G, Barbanti P, Aurilia C, Vanacore N, Pauletti C, Meco G.
    Mov Disord; 2002 Sep 12; 17(5):1026-30. PubMed ID: 12360553
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.